Negocios · 10/9/19971 min de lectura
Central Georgia Plasma Lab, Inc.; Revocation of U.S. License No. 0649-001
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing the revocation of the establishment license (U.S. License No. 0649-001) and product license issued to Central Georgia Plasma Lab, Inc. (Central Georgia), for the manufacture of Source Plasma. A notice of opportunity for a hearing on a proposal to revoke the licenses was published in the Federal Register of May 20, 1994 (59 FR 26503). Central Georgia subsequently requested a hearing. However, in a letter dated July 12, 1996, the firm notified FDA that it had ceased operations effective June 25, 1996, and voluntarily requested revocation of its licenses. The request for an opportunity for a hearing on the issue of license revocation became moot. FDA, therefore, proceeded to revoke the firm's licenses.